Boardroom Alpha
Start trial
10-K primary document
PAR · Annual Report (Form 10-K) · Filed February 26, 2026

Par Technology Corp — 10-K exhibit

aex1018amendmentxemploymen.htm
Par Technology Corp on Boardroom Alpha
Document
Exhibit 10.18
December 10, 2025


Mr. Savneet Singh
c/o PAR Technology Corporation
8383 Seneca Turnpike
New Hartford, NY 13413

Re:    Amendment to Amended and Restated Employment Letter: Service as Chief Executive Officer

Dear Savneet:

    This Amendment (“Amendment”) sets forth certain amendments to the Amended and Restated Employment Agreement dated May 9, 2023 (as previously amended, the “Employment Letter”) between you and PAR Technology Corporation (the “Company”). Capitalized terms used in this Amendment and not otherwise defined herein shall have the meanings ascribed to them in the Employment Letter. You and the Company agree that as of the Effective Date (defined below) the Employment Letter is amended as follows:
1.    The below paragraph from Section 8(c) of the Employment Letter is removed:

For purposes of this Letter, the term “Change of Control Protection Period” shall mean the period beginning the third month immediately before and ending the 13th month immediately following the effective date of a Change of Control.

2.     The paragraph removed pursuant to Section 1 of this Amendment is replaced with the following:

For purposes of this Letter, the term “Change of Control Protection Period” shall mean the period beginning the third month immediately before and ending the 21st month immediately following the effective date of a Change of Control.

Except as set forth in this Amendment and amended hereby, all other terms and provisions of the Employment Letter shall remain unchanged and in full force and effect.

    If you agree with the terms and conditions of this Amendment, please evidence your agreement by countersigning and dating this Amendment in the space indicated and return it to me. Your signature will acknowledge that you have read and understand and agree to the terms and conditions of this Amendment. This Amendment shall be effective on the date of your countersignature on this Amendment (“Effective Date”).





[Signature Page Immediately Follows]



Feel free to contact me if you have questions or if you need any additional information.

                        Sincerely,

    
                        By: /s/Bryan A. Menar                
                        Name:    Bryan A. Menar
Title:    Chief Financial Officer

Accepted and Agreed to:


/s/Savneet Singh            
Savneet Singh

Dated: 12/10/2025





Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer